Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Cash & Current Investments (2010 - 2026)

Repligen's (RGEN) quarterly Cash & Current Investments came in at $1.0 billion in Q2 2026, up 43.06% year-over-year from $708.9 million in Q2 2025, and up 2.81% quarter-over-quarter from $986.4 million in Q1 2026.

Analysis

Repligen (RGEN) Cash & Current Investments (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Cash & Current Investments for 17 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Current Investments rose 43.06% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 43.06% increase from a year earlier, with the FY2025 full-year figure at $969.2 million, up 27.93% from the prior year.
  • Cash & Current Investments was $1.0 billion for Q2 2026 at Repligen, up from $986.4 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.0 billion in Q2 2026 and troughed at $573.4 million in Q3 2022.
  • A 5-year average of $735.4 million and a median of $728.8 million in 2025 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments slipped 18.77% in 2022 and surged 43.06% in 2026, its largest moves.
  • Over 5 years, Cash & Current Investments stood at $623.8 million in 2022, then rose by 20.45% to $751.3 million in 2023, then rose by 0.84% to $757.6 million in 2024, then gained by 27.93% to $969.2 million in 2025, then climbed by 4.63% to $1.0 billion in 2026.
  • The last three Cash & Current Investments figures came in at $1.0 billion (Q2 2026), $986.4 million (Q1 2026), and $969.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.06 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 4.35 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1.76 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 1.17 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 1.02 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 264.71 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 1.62 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 1.01 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 552.03 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 217.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Bn
Mar 31, 2026 986.41 Mn
Dec 31, 2025 969.24 Mn
Sep 30, 2025 748.75 Mn
Jun 30, 2025 708.86 Mn
Mar 31, 2025 697.23 Mn
Dec 31, 2024 757.64 Mn
Sep 30, 2024 783.96 Mn
Jun 30, 2024 809.15 Mn
Mar 31, 2024 780.62 Mn
Dec 31, 2023 751.32 Mn
Sep 30, 2023 630.78 Mn
Jun 30, 2023 603.66 Mn
Mar 31, 2023 618.02 Mn
Dec 31, 2022 623.76 Mn
Sep 30, 2022 573.36 Mn
Jun 30, 2022 596.51 Mn
Mar 31, 2022 584.64 Mn
Dec 31, 2021 603.81 Mn
Sep 30, 2021 621.10 Mn